Atlas Trials

A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn

Clinical trial NCT05701540 · UNKNOWN

Trial details

NCT number
NCT05701540
Sponsor
HK inno.N Corporation
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2023-03-24
Primary completion
2024-12-31
Enrollment
338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.